Schedule 13G ownership disclosure

MEDICENNA THERAPEUTICS CORP

Security class unavailable · CUSIP: 58490H107

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
17,935,000
Percent of class
32.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-021964
Form type
SC 13G
Filer
Medicenna Therapeutics Corp.
CIK
CIK 1807983
Filed
Feb 12, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub